Galenicum was founded in Barcelona in 2003 with the mission of improving the quality and affordability of pharmaceutical products. This purpose has remained at the core through all these years, while the company has grown to become a global ecosystem of several businesses within the pharmaceutical sector.
Galenicum covers the entire industry value chain and has commercial agreements in place that span more than fifty countries worldwide.
Galenicum is continuing its adventure to become a global specialty pharmaceutical company, bringing further innovation to products in the years to come.
Multiple partnership models with other pharmaceutical companies at any stage of the value chain – from R&D right through production and global supply.
Broad portfolio of high-quality APIs and pharmaceutical products, covering most therapeutic areas and technologies.
State-of-the-art manufacturing facility near Madrid with a production capacity of over 50 million packs per year, and global supply.
High-quality Finished Dosage Forms in multiple formats and technologies: liquids, ointments, creams, sachets, powders, nasal sprays, tablets and hard gelatin capsules.
'Vitae' affiliates in Latin American markets as well as distribution partners across Asia and the Middle East.
In-licensing of high-quality Finished Dosage Forms to complete a broad portfolio of pharmaceutical products, covering most therapeutic areas and technologies.
Development and in-licensing of innovative and high-quality dermatological products.
Sales team based in Spain covering the national market. Considering third-party distribution deals to further enable international expansion.